Evidence map›Paper›PMID 33999938›Full record

ArticlePloS one2021

Characterization of oral swab samples for diagnosis of pulmonary tuberculosis.

Rachel C Wood, Alfred Andama, Gleda Hermansky, Stephen Burkot, Lucy Asege, Mukwatamundu Job, David Katumba, Martha Nakaye, Sandra Z Mwebe, Jerry Mulondo and 15 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07517471 (Start4All - Start Taking Action for TB Diagnosis SCREEN-TB), which is not on this map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07517471 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Start4All - Start Taking Action for TB Diagnosis SCREEN-TB

TypeinterventionalSponsorLiverpool School of Tropical MedicineRan2026 to 2027Enrolled37,000ConditionsTB - TuberculosisArmsNear point of care (NPOC) NAATs, Low-complexity nucleic acid amplification tests (LC-NAATs), LC-NAAT using pooled testing, Portable Chest X-ray Image Acquisition, Computer-Aided Detection (CAD) Chest X-ray (CXR-AI)
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Diagnostic Accuracy of Molecular Testing on Saliva and Oral Swabs for Pulmonary Tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Oral Rinse as an Alternative Diagnostic Specimen for Detection of Tuberculosis.American journal of respiratory and critical care medicine · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. High-sensitivity detection ofJournal of clinical microbiology · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 2 countries.

Rachel C WoodDepartment of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, United States of America.
Alfred AndamaInfectious Diseases Research Collaboration, Kampala, Uganda.
Gleda HermanskyIntellectual Ventures Laboratory, Bellevue, Washington, United States of America.
Stephen BurkotIntellectual Ventures' Global Good Fund, Bellevue, Washington, United States of America.
Lucy AsegeInfectious Diseases Research Collaboration, Kampala, Uganda.
Mukwatamundu JobInfectious Diseases Research Collaboration, Kampala, Uganda.
David KatumbaInfectious Diseases Research Collaboration, Kampala, Uganda.
Martha NakayeInfectious Diseases Research Collaboration, Kampala, Uganda.
Sandra Z MwebeInfectious Diseases Research Collaboration, Kampala, Uganda.
Jerry MulondoInfectious Diseases Research Collaboration, Kampala, Uganda.
Christine M BachmanIntellectual Ventures' Global Good Fund, Bellevue, Washington, United States of America.
Kevin P NicholsIntellectual Ventures Laboratory, Bellevue, Washington, United States of America.
Anne-Laure M Le NyIntellectual Ventures Laboratory, Bellevue, Washington, United States of America.
Corrie OrtegaIntellectual Ventures Laboratory, Bellevue, Washington, United States of America.
Rita N OlsonDepartment of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, United States of America.
Kris M WeigelDepartment of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, United States of America.
Alaina M OlsonDepartment of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, United States of America.
Damian MadanIntellectual Ventures Laboratory, Bellevue, Washington, United States of America.
David BellIntellectual Ventures' Global Good Fund, Bellevue, Washington, United States of America.
Adithya CattamanchiDivision of Pulmonary and Critical Care Medicine and Center for Tuberculosis, Zuckerberg San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.ORCID 0000-0002-6553-2601
William WorodriaInfectious Diseases Research Collaboration, Kampala, Uganda.
Fred C SemitalaInfectious Diseases Research Collaboration, Kampala, Uganda.
Akos SomoskoviIntellectual Ventures' Global Good Fund, Bellevue, Washington, United States of America.
Gerard A CangelosiDepartment of Environmental and Occupational Health Sciences, School of Public Health, University of Washington, Seattle, Washington, United States of America.
Kyle J MinchIntellectual Ventures Laboratory, Bellevue, Washington, United States of America.ORCID 0000-0003-2447-5759
Infectious Diseases Research Collaboration · UGBellevue Hospital Center · USUniversity of Washington · USIntellectual Ventures (United States) · USSan Francisco General Hospital · US

Funding

Non-invasive diagnosis of adult pulmonary tuberculosisR01AI139254 · NIAID · UNIVERSITY OF WASHINGTON · PI CANGELOSI, GERARD A · 2019 to 2022
$1.3M
NIAID NIH HHS R01 AI139254
6 · The paper itself

Abstract

Oral swab analysis (OSA) has been shown to detect Mycobacterium tuberculosis (MTB) DNA in patients with pulmonary tuberculosis (TB). In previous analyses, qPCR testing of swab samples collected from tongue dorsa was up to 93% sensitive relative to sputum GeneXpert, when 2 swabs per patient were tested. The present study modified sample collection methods to increase sample biomass and characterized the viability of bacilli present in tongue swabs. A qPCR targeting conserved bacterial ribosomal rRNA gene (rDNA) sequences was used to quantify bacterial biomass in samples. There was no detectable reduction in total bacterial rDNA signal over the course of 10 rapidly repeated tongue samplings, indicating that swabs collect only a small portion of the biomass available for testing. Copan FLOQSwabs collected ~2-fold more biomass than Puritan PurFlock swabs, the best brand used previously (p = 0.006). FLOQSwabs were therefore evaluated in patients with possible TB in Uganda. A FLOQSwab was collected from each patient upon enrollment (Day 1) and, in a subset of sputum GeneXpert Ultra-positive patients, a second swab was collected on the following day (Day 2). Swabs were tested for MTB DNA by manual IS6110-targeted qPCR. Relative to sputum GeneXpert Ultra, single-swab sensitivity was 88% (44/50) on Day 1 and 94.4% (17/18) on Day 2. Specificity was 79.2% (42/53). Among an expanded sample of Ugandan patients, 62% (87/141) had colony-forming bacilli in their tongue dorsum swab samples. These findings will help guide further development of this promising TB screening method.

Indexed as

AdolescentAdultDNA, RibosomalFemaleGenes, BacterialHumansMaleMycobacterium tuberculosisPolymerase Chain ReactionRNA, BacterialRNA, RibosomalSpecimen HandlingTuberculosis, PulmonaryUgandaYoung AdultDNA, RibosomalRNA, BacterialRNA, Ribosomal

Identifiers

PMID33999938
PMCPMC8128230
OpenAlexW3160856701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.